ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: DeVita Vs. Lincoln; ACS Says It Will Take “New Initiatives In Political Forums”

March 17, 1978

Two Cooperative Groups Renamed ECOG-ACRIN

September 23, 2011

CCIRC Loses Policy Making, Protocol Review

September 26, 1975

Former Group Chair Responds To Niederhuber: Change But Don’t Dissolve Cooperative Groups

July 2, 2010

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002